𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Durability of Lamivudine associated HBe antigen seroconversion in Chinese-Canadian patients with chronic hepatitis B virus infection

✍ Scribed by Ramji, Alnoor S.; Yoshida, Eric M.; Kwan, Peter W.


Book ID
123155645
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
217 KB
Volume
124
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Efficacy of lamivudine in patients with
✍ Nicolaos C. Tassopoulos; Riccardo Volpes; Giuseppe Pastore; Jenny Heathcote; Mar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 1 views

This placebo controlled, double-blind study evaluated the efficacy and safety of lamivudine in patients with hepatitis B e antigen (HBeAg)-negative/hepatitis B virus (HBV) DNA-positive chronic hepatitis B. Patients were randomized to receive 100 mg lamivudine orally once daily for 52 weeks (n ‫؍‬ 60

Dane Particle-Associated Hepatitis B e A
✍ Giovanni Raimondo; Serafino Recchia; Carla Lavarini; Osvaldo Crivelli; Mario Riz 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 642 KB

A commercial radioimmunoassay was adapted to detect serum Dane particle-associated HBeAg in patients whose sera contained the homologous antibody. HBeAg was released from Dane particles with guanidine HC1. Dane particles were separated from anti-HBe by gel-filtration (Sepharose 4B) and ultracentrif